News

2020

Nexstim reports promising clinical outcomes of first 55 patients completing SmartFocus® rTMS treatment of Major Depressive Disorder

17 April 2020

Sequana Medical announces first-in-human data of Direct Sodium Removal (DSR) therapy published in Circulation

10 January 2020

Sequana Medical announces first patient enrolled in RED DESERT – REpeated Dose alfapump® DSR study for Treatment of diuretic-resistant heart failure patients

7 January 2020

2019

Confo Therapeutics reports grant of two key patents for ConfoBodies™

2 December 2019

Sequana Medical announces first patient enrolled in North American alfapump® pivotal study (POSEIDON)

25 September 2019

FierceBiotech names Confo Therapeutics as one of its “Fierce 15” Biotech Companies of 2019

23 September 2019

iSTAR Medical announces € 40 million Series C financing

5 September 2019

Mainstay Medical announces completion of financing transactions

30 July 2019

iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

10 July 2019

Confo Therapeutics and DyNAbind announce drug discovery collaboration to identify novel GPCR-modulating compounds

3 July 2019

Mainstay Medical announces completion of pre-submission meeting with FDA regarding Pre-Market Approval (PMA) application for ReActiv8

26 June 2019

Confo Therapeutics raises € 30 million in Series A financing

7 May 2019

• 1
• 2
• 3
• 4
• 5